Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline and Expand Single Cell Analysis Drug Development Platform
Immunitas Therapeutics (“Immunitas”), a single cell genomics-based therapeutics company, today announced the completion of a $58 […]
Holmusk Signs Agreements with UTHealth and The Harris Center
Holmusk, a leading global data science and health technology company building the world’s largest Real-World […]
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors
Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly […]
Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised […]
ViroCell Announces New Board Appointments
ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, today […]
Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units
Eli Lilly and Company (NYSE: LLY) today announced executive leadership changes and the creation of neuroscience […]
ConcertAI Names Catherine Richards as its First Chief Data Officer and RWD Products Head
ConcertAI, LLC (ConcertAI), a market leader for real-world data (RWD) and enterprise AI technology solutions […]
Alder Hey Launches First Startup Collaboration Programme
Today, Alder Hey Children’s NHS Foundation Trust is launching our first start-up accelerator programme: Alder […]
GeneQuantum Announces a Key Leadership Appointment
GeneQuantum Healthcare, an industry leading biopharmacetucial company dedicated to next generation bioconjugate drugs through innovative […]
Musculoskeletal (MSK) Funding Opens
Funding has been created to support Integrated Care Systems (ICSs) who have an active interest […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more